nad has been researched along with Cognition Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandez, E; Goldstein, DS; Martinez, PA; Strong, R; Sullivan, P; Wey, MC | 1 |
| Carey, M; Hockenberry, M; Kaemingk, K; Krull, K; Miketova, P; Moore, IM; Pasvogel, A | 1 |
| Amamoto, T; Fujiwara, M; Kawachi, A; Mine, K; Okada, M; Tomonaga, M; Yazawa, K | 1 |
| Bender, DA | 1 |
1 review(s) available for nad and Cognition Disorders
| Article | Year |
|---|---|
Tryptophan and niacin nutrition--is there a problem?
Topics: Adult; Animals; Cognition Disorders; Environmental Exposure; Humans; Hydrolases; Iron Deficiencies; Kynurenine 3-Monooxygenase; Lead Poisoning; Liver; Mixed Function Oxygenases; NAD; NADP; Neoplasms; Niacin; Nutritional Requirements; Oxidative Stress; Trace Elements; Tryptophan; Zinc | 1996 |
3 other study(ies) available for nad and Cognition Disorders
| Article | Year |
|---|---|
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Body Weight; Cognition Disorders; Cytosol; Disease Models, Animal; Dopamine; Female; Genotype; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Parkinson Disease; Time Factors; Tyrosine 3-Monooxygenase | 2012 |
Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia.
Topics: Analysis of Variance; Antimetabolites, Antineoplastic; Child; Chromatography, Gas; Cognition Disorders; Female; Humans; Intelligence Tests; Male; Methotrexate; NAD; Oxidation-Reduction; Palmitic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Psychomotor Performance; Risk Factors; Statistics, Nonparametric; Stearic Acids | 2008 |
The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats.
Topics: Animals; Arachidonic Acid; Brain; Brain Chemistry; Cognition Disorders; Docosahexaenoic Acids; Hippocampus; Ischemic Attack, Transient; Lipid Metabolism; Male; Maze Learning; NAD; Rats; Rats, Wistar; Reperfusion Injury; Space Perception | 1996 |